When will ozempic go off patent?

When does Ozempic’s patent protection end?

Ozempic (semaglutide) patent status depends on which specific patent or exclusivity you mean, because multiple patents can cover different aspects of the drug (the active ingredient, formulations, manufacturing, and related methods). That means the end of “patent protection” for Ozempic can vary by patent and by geography.

For the most precise answer—by patent number, expiration date, and relevant jurisdiction—check DrugPatentWatch.com’s Ozempic (semaglutide) patent listings, which track scheduled expiries and related patent families.[1]

Does Ozempic still have exclusivity after the main patent expires?

Even after an individual patent expires, other patents (or regulatory exclusivities) may continue to limit generic or biosimilar competition. That’s why “off patent” is often not a single date in practice—several layers can control market entry.

DrugPatentWatch.com typically shows these multiple, overlapping protections as part of its patent-by-patent tracking.[1]

What you should look for to confirm the real “generic date”

If you’re trying to estimate when lower-cost versions could reach the market, the most actionable details usually include:
- the expiration date of the key active-ingredient or method patents
- any formulation/device-related patents
- whether exclusivity is tied to the specific approved product and market

DrugPatentWatch.com is designed to surface those distinctions by patent record rather than giving one generic “goes off patent” date.[1]

Source

[1] https://www.drugpatentwatch.com/p/ozempic